Chapter 1. Methodology and Scope
1.1. Research Methodology
1.2. Research Scope & Assumptions
Chapter 2. Executive Summary
Chapter 3. Global Animal Microbiome Market Snapshot
Chapter 4. Global Animal Microbiome Market Variables, Trends & Scope
4.1. Market Segmentation & Scope
4.2. Drivers
4.3. Challenges
4.4. Trends
4.5. Key Investments and Funding
4.6. Industry Analysis – Porter’s Five Forces Analysis
4.7. Competitive Landscape & Market Share Analysis
4.8. Technology Advancement in Animal Microbiome
Chapter 5. Market Segmentation 1: Product Estimates & Trend Analysis
5.1. Product Type & Market Share, 2025 & 2035
5.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Product:
5.2.1. Phage Therapy Product
5.2.2. Functional Food
5.2.2.1. Probiotics
5.2.2.2. Prebiotics
5.2.2.3. Others
5.2.3. Sequencing Platforms
5.2.4. Feed Additives/Functional Ingredients
5.2.5. Alternative Proteins and Alternative Feed
5.2.6. Other Innovative Microbiome Products and Therapies
Chapter 6. Animal Microbiome Market Segmentation 2: Application Estimates & Trend Analysis
6.1. Application Analysis & Market Share, 2025 & 2035
6.2. Market Size (Value US$ Mn) & Forecasts and Trend Analyses, 2022 to 2035 for the following Application:
6.2.1. Disease Therapeutics
6.2.2. Diagnostics
6.2.3. Nutrition
Chapter 7. Animal Microbiome Market Segmentation 3: Regional Estimates & Trend Analysis
7.1. North America
7.1.1. North America Animal Microbiome Market revenue (US$ Million) estimates and forecasts by product, 2022-2035
7.1.2. North America Animal Microbiome Market revenue (US$ Million) estimates and forecasts by application, 2022-2035
7.1.3. North America Animal Microbiome Market revenue (US$ Million) estimates and forecasts by country, 2022-2035
7.1.3.1. U.S.
7.1.3.2. Canada
7.2. Europe
7.2.1. Europe Animal Microbiome Market revenue (US$ Million) by product, 2022-2035
7.2.2. Europe Animal Microbiome Market revenue (US$ Million) by application, 2022-2035
7.2.3. Europe Animal Microbiome Market revenue (US$ Million) by country, 2022-2035
7.2.3.1. Germany
7.2.3.2. Poland
7.2.3.3. France
7.2.3.4. Italy
7.2.3.5. Spain
7.2.3.6. UK
7.2.3.7. Rest of Europe
7.3. Asia Pacific
7.3.1. Asia Pacific Animal Microbiome Market revenue (US$ Million) by product, 2022-2035
7.3.2. Asia Pacific Animal Microbiome Market revenue (US$ Million) by application, 2022-2035
7.3.3. Asia Pacific Animal Microbiome Market revenue (US$ Million) by country, 2022-2035
7.3.3.1. China
7.3.3.2. India
7.3.3.3. Japan
7.3.3.4. Australia
7.3.3.5. Rest of Asia Pacific
7.4. Latin America
7.4.1. Latin America Animal Microbiome Market revenue (US$ Million) by product, (US$ Million)
7.4.2. Latin America Animal Microbiome Market revenue (US$ Million) by application, (US$ Million)
7.4.3. Latin America Animal Microbiome Market revenue (US$ Million) by country, (US$ Million) 2022-2035
7.4.3.1. Brazil
7.4.3.2. Rest of Latin America
7.5. MEA
7.5.1. MEA revenue Animal Microbiome Market revenue (US$ Million) by product, (US$ Million) 2022-2035
7.5.2. MEA revenue Animal Microbiome Market revenue (US$ Million) by country, (US$ Million) 2022-2035
7.5.2.1. South Africa
7.5.2.2. Rest of MEA
Chapter 8. Competitive Landscape
8.1. Major Mergers and Acquisitions/Strategic Alliances
8.2. Company Profiles
8.2.1. Adisseo France SAS
8.2.2. Animal Biome, Inc
8.2.3. ANIZOME LLC
8.2.4. Arm & Hammer Animal Nutrition
8.2.5. Cargill
8.2.6. Chr. Hansen Holding A/S
8.2.7. Cytophage Technologies Inc.
8.2.8. DuPont Industrial Biosciences
8.2.9. Elanco Animal Health
8.2.10. EnBiotix, Inc.
8.2.11. Gnubiotics Sciences SA
8.2.12. Hill's Pet Nutrition, Inc.
8.2.13. Intralytix
8.2.14. Jefo Nutrition Inc.
8.2.15. Koninklijke DSM N.V. (Royal DSM)
8.2.16. Lallemand Inc.
8.2.17. Land O'Lakes, Inc.
8.2.18. Leiber GmbH
8.2.19. MicroSintesis
8.2.20. Native Microbials
8.2.21. NomNomNow Inc.
8.2.22. Novozymes A/S
8.2.23. Novus International, Inc.
8.2.24. Ocean Harvest Technology
8.2.25. Orion Pharma Animal Health
8.2.26. Phage Technologies SA
8.2.27. Phagelux, Inc.
8.2.28. Phibro Animal Health Corporation
8.2.29. Phytobiotics Futterzusatzstoffe GmbH
8.2.30. Primal Health, LLC
8.2.31. ProDigest
8.2.32. Proteon Pharmaceuticals
8.2.33. Purina Animal Nutrition
8.2.34. Resilient Biotics
8.2.35. Tonisity International Limited
8.2.36. Vetanco
8.2.37. VetoPhage
This study employed a multi-step, mixed-method research approach that integrates:
This approach ensures a balanced and validated understanding of both macro- and micro-level market factors influencing the market.
Secondary research for this study involved the collection, review, and analysis of publicly available and paid data sources to build the initial fact base, understand historical market behaviour, identify data gaps, and refine the hypotheses for primary research.
Secondary data for the market study was gathered from multiple credible sources, including:
These sources were used to compile historical data, market volumes/prices, industry trends, technological developments, and competitive insights.
Primary research was conducted to validate secondary data, understand real-time market dynamics, capture price points and adoption trends, and verify the assumptions used in the market modelling.
Primary interviews for this study involved:
Interviews were conducted via:
Primary insights were incorporated into demand modelling, pricing analysis, technology evaluation, and market share estimation.
All collected data were processed and normalized to ensure consistency and comparability across regions and time frames.
The data validation process included:
This ensured that the dataset used for modelling was clean, robust, and reliable.
The bottom-up approach involved aggregating segment-level data, such as:
This method was primarily used when detailed micro-level market data were available.
The top-down approach used macro-level indicators:
This approach was used for segments where granular data were limited or inconsistent.
To ensure accuracy, a triangulated hybrid model was used. This included:
This multi-angle validation yielded the final market size.
Market forecasts were developed using a combination of time-series modelling, adoption curve analysis, and driver-based forecasting tools.
Given inherent uncertainties, three scenarios were constructed:
Sensitivity testing was conducted on key variables, including pricing, demand elasticity, and regional adoption.